Indicated for use in patients with atherosclerotic disease of the femoral and infrapopliteal arteries and for the treatment of insufficient results after Percutaneous Transluminal Angioplasty (PTA).*
140 μm thin struts
Thinner than the leading brands1
4F low profile
Improved acute outcomes vs. 6F2
Clinically proven2,3
Long term safety and efficacy (24-month data), even in calcified lesions4,5
| Proximal Shaft | |
|---|---|
| Catheter type | OTW |
| Recommended guide wire | 0.018” |
| Stent material | Nitinol |
| Strut thickness | 140 μm |
| Strut width | 85 μm |
| Stent coating | proBIO™ (Amorphous Silicon Carbide) |
| Stent markers | 6 gold markers each end |
| Sizes | ø 4.0 - 7.0 mm; L:20 - 200 mm |
| Proximal shaft | 3.6F, hydrophobic coating |
| Usable length | 90 cm and 135 cm |
| Stent ø (mm) |
Catheter length 90 cm Stent length (mm) |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 30 | 40 | 60 | 80 | 100 | 120 | 150 | 170 | 200 | |||||
| 4F | 4 | 377456 | 377457 | 377458 | 377459 | 377460 | 366808 | 366809 | 3366810 | 366811 | 3366812 | |||
| 5 | 377461 | 377462 | 377463 | 377464 | 377465 | 366813 | 366814 | 3366815 | 3366816 | 366817 | ||||
| 6 | 377466 | 377467 | 377468 | 377469 | 377470 | 366818 | 366819 | 3366820 | 366821 | 366822 | ||||
| 7 | 377471 | 377472 | 377473 | 377474 | 377475 | 366823 | 3366824 | 366825 | 366826 | 366827 | ||||
| Stent ø (mm) |
Catheter length 135 cm Stent length (mm) |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 30 | 40 | 60 | 80 | 100 | 120 | 150 | 170 | 200 | |||||
| 4F | 4 | 377476 | 377477 | 377478 | 377479 | 377480 | 366828 | 366829 | 366830 | 366831 | 366832 | |||
| 5 | 377481 | 377482 | 377483 | 377484 | 377485 | 366833 | 366834 | 366835 | 366836 | 366837 | ||||
| 6 | 377486 | 377487 | 377488 | 377489 | 377490 | 366838 | 366839 | 366840 | 366841 | 366842 | ||||
| 7 | 377491 | 377492 | 377493 | 377494 | 377495 | 366843 | 366844 | 366845 | 366846 | 366847 | ||||